Chemical Compound

N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl Hydroxamic Acid; N-Hydroxy-2-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]acetamide;

CAS Registry Number 161314-17-6
返回搜索 申请报价
N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl Hydroxamic Acid; N-Hydroxy-2-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]acetamide; 结构式
Primary record

N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl Hydroxamic Acid; N-Hydroxy-2-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]acetamide;

库存
8,703 克
纯度
98.9 %
CAS
161314-17-6

化合物标识与属性

CAS
161314-17-6
PubChem CID
448002
SMILES
CC(C)CN(CC(=O)NO)S(=O)(=O)C1=CC=C(C=C1)OC
Canonical SMILES
COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(C)C)cc1

名称与同义词

  • NNGH
  • mmp-3 inhibitor ii
  • 1rmz
  • MMP Inhibitor Set I
  • 161314-17-6
  • 1z3j
  • AC1L9LHM
  • RefChem:163594
  • UNII-9P3H27MP46
  • 9P3H27MP46
  • MMP-3
  • CHEMBL-311932
  • CGS 27023A Analog 3
  • SCHEMBL598146
  • CHEMBL311932
  • NNGH?? Z? M?
  • orb1704984
  • BDBM13080
  • C13H20N2O5S
  • CTK8G1958
  • JIRXORZYIXSWOB-UHFFFAOYSA-N
  • N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID
  • GLXC-01793
  • LGA31417
  • NNGH, >=98% (HPLC)
  • ZINC3818629
  • CID448002
  • IN1253
  • IN1261
  • MFCD02179370
  • AKOS040744915
  • CCG-207858
  • DB08271
  • n-isobutyl-n-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid
  • NCGC00388616-04
  • DS-017133
  • HY-119711
  • J869.968B
  • CS-0077845
  • NS00069310
  • N-Hydroxy-2-((N-isobutyl-4-methoxyphenyl)sulfonamido)acetamide
  • N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]acetamide
  • AcetaMide, N-hydroxy-2-[[(4-Methoxyphenyl)sulfonyl](2-Methylpropyl)aMino]-
  • G92435
  • MMP-3 Inhibitor II - CAS 161314-17-6
  • N-hydroxy-2-((4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino)acetamide
  • N-Hydroxy-2-(((4-methoxyphenyl)sulfonyl)(2-methylpropyl)amino)acetamide
  • N-Isobutyl-N-(4-methoxyphenylsulfonyl)-glycylhydroxamic Acid
  • Q27097492
  • 2-((4-Methoxyphenyl)sulfonyl-(2-methylpropyl)amino)-N-oxidanyl-ethanamide
  • Acetamide, N-hydroxy-2-(((4-methoxyphenyl)sulfonyl)(2-methylpropyl)amino)-
  • N-hydroxy-2-[N-(2-methylpropyl)4-methoxybenzenesulfonamido]acetamide
  • 2-[Isobutyl(4-methoxyphenylsulfonyl)amino]acetohydroximic acid
  • 2-[Isobutyl(4-methoxyphenylsulfonyl)amino]ethanehydroxamic acid
  • NGH
  • 2-[isobutyl-(4-methoxyphenyl)sulfonyl-amino]ethanehydroxamic acid
  • 2-[Isobutyl[(4-methoxyphenyl)sulfonyl]amino]acetohydroximic acid
  • 2-[N-Isobutyl-N-(4-methoxyphenylsulfonyl)amino]acetohydroxamic acid
  • N-hydroxy-2-(N-(2-methylpropyl)4-methoxybenzenesulfonamido)acetamide
  • 2-[(2-Methylpropyl)[(4-methoxyphenyl)sulfonyl]amino]acetohydroximic acid
  • Acetamide,n-hydroxy-2-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]-
  • N-hydroxy-2-[(4-methoxybenzene)(2-methylpropyl)sulfonamido]acetamide
  • N-hydroxy2-[N-(2-methylpropyl)4-methoxybenzenesulfonamido]ethanimidic acid
  • MMP-3 Inhibitor II;BML-205, N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid
  • N-hydroxy-N~2~-[(4-methoxyphenyl)sulfonyl]-N~2~-(2-methylpropyl)glycinamide
  • N-Isobutyl-N-(4-methoxyphenylsulfonyl)glycyl Hydroxamic Acid; N-Hydroxy-2-[[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino]acetamide;